Welcome to Lumino’s Media Hub.
Here you’ll find everything you need to stay in the loop with our latest news, updates, and resources.
Join us. Let’s make better mental health for everyone.
Becky Cotton and Mo Morgan
Co-Founders
For media enquiries, interviews, or more information, get in touch with our media team. We’re here to help with expert commentary, speaker appearances, or whatever else you might need.
For all enquiries, get in touch with the team at 📧 [email protected] or by calling us direct on +44 (0)117 2449010.
Want to know what we’ve been up to? We post all our news on our LinkedIn page. See how we’re shaking things up in digital health.
Lumino is on a mission to create better care for all.
We combine behavioural science, clinical evidence and thoughtful digital design to deliver clinical-grade interventions through engaging digital experiences.
Our first product, Seren, is a regulated digital therapeutic for menopause support, delivering Cognitive Behavioural Therapy (CBT) through a structured digital intervention.
Our funders and partners include Innovate UK, Exeter University, NIHR, Bayer, Civtech, the Scottish Government and the NHS in Scotland.
Cognitive Behavioural Therapy (CBT) is an evidence-based non-hormonal treatments for menopausal symptoms. It helps people understand and change the patterns of thoughts, emotions, behaviours, and stress responses that can make symptoms feel more intense or harder to manage. CBT has been shown to reduce the impact of hot flushes and night sweats, improve sleep, and support mood and wellbeing. It is recommended by both the British Menopause Society and the North American Menopause Society.
Despite this, access to menopause-specific CBT is limited, and many patients are unable to receive timely support.
Seren is Lumino’s digital therapeutic designed to close this treatment gap. Seren delivers a structured, clinically informed CBT programme for menopause through a digital platform, supporting people to build practical skills for managing symptoms, improving quality of life, and sustaining long-term wellbeing. Seren is being developed with input from clinical and academic partners, and is supported by Innovate UK, NIHR, Bayer, and the Scottish Government.